Psychotic Disorders - Ghana

  • Ghana
  • Revenue in the Psychotic Disorders market is projected to reach US$6.81m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.70%, resulting in a market volume of US$7.05m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$2,257.00m in 2024).
  • In relation to total population figures, per person revenues of US$25.42 are generated in 2024.

Key regions: Japan, Australia, Europe, India, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Psychotic Disorders market in Ghana is experiencing significant growth and development due to several factors.

Customer preferences:
Customers in Ghana are increasingly seeking effective treatments for psychotic disorders, such as schizophrenia and bipolar disorder. They are looking for medications that can alleviate symptoms and improve their quality of life. Additionally, there is a growing demand for holistic approaches to treatment, including psychotherapy and support services.

Trends in the market:
One of the key trends in the Psychotic Disorders market in Ghana is the increasing availability of antipsychotic medications. Pharmaceutical companies are expanding their product portfolios to include a wide range of medications that target different symptoms and have fewer side effects. This trend is driven by the growing understanding of the underlying neurobiology of psychotic disorders and the need for personalized treatment options.Another trend in the market is the integration of technology in the delivery of mental health services. Telemedicine and mobile health applications are being used to provide remote consultations, monitor medication adherence, and offer support to patients. This trend is particularly beneficial in Ghana, where access to mental health services in rural areas is limited.

Local special circumstances:
Ghana faces unique challenges in addressing the needs of individuals with psychotic disorders. There is a shortage of mental health professionals, including psychiatrists and psychologists, which limits the availability of specialized care. Additionally, there is a stigma associated with mental illness, leading to underreporting and delayed treatment-seeking behavior.

Underlying macroeconomic factors:
The development of the Psychotic Disorders market in Ghana is influenced by several macroeconomic factors. The country's growing economy has led to an increase in disposable income, allowing individuals to afford the cost of medications and treatment. Additionally, the government has recognized the importance of mental health and has implemented policies to improve access to care and reduce stigma.In conclusion, the Psychotic Disorders market in Ghana is experiencing growth and development due to increasing customer preferences for effective treatments, the availability of a wider range of medications, the integration of technology in mental health services, and the unique local circumstances and macroeconomic factors.

Methodology

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Patients
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)